Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Packaging, Labeling, and Kitting Services for Military Shipment

Active

Federal

Response Deadline07/29/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract requires the secondary packaging, hazard labeling, and kitting of Oral Rehydration Salts into sealed containers that meet strict military compliance standards, specifically MIL-STD-129 and DLA RP001, ensuring readiness for deployment in defense and medical supply chains. All packaging must be durable, tamper-evident, and properly labeled with hazard information to align with Department of Defense requirements for transport, storage, and field use. The work is centered on preparing medical supplies for reliable logistical handling under demanding operational conditions. This subcontract opportunity, issued under the NAICS code 325990 by the Medical Supply Chain Pharm FSA within the Department of Defense, specifies that performance will be carried out at FPO, ZIP 96691. Proposals must be submitted by July 29, 2026, with the solicitation posted on July 23, 2026. Interested parties must adhere to all technical and procedural guidelines governing military packaging and labeling to qualify, as noncompliance will result in disqualification. The contract underscores a critical need for precision and regulatory adherence in supporting military medical readiness through properly prepared and documented pharmaceutical kits.

General Info

Packaging Oral Rehydration Salts to MIL-STD-129 and DLA RP001 standards for military medical deployment.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325990View NAICS

Place of Performance

FPO, AP, 96691, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 23

subcontract

Response DeadlineJul 29

Submission deadline

Response Deadline

07/29/2026, 05:00:00 PM UTCin about 3 hours

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Secondary packaging, hazard labeling, and kitting of Oral Rehydration Salts into military-compliant sealed containers per MIL-STD-129 and DLA RP001 standards.

Similar Contracts

Same NAICS industry code

Supplier of Nonmetallic Materials / Raw ComponentsThe contract is for the supply of raw nonmetallic materials including thermoplastics, synthetic rubber, and polymer resins to support the fabrication of hose assemblies under a subcontract arrangement. These materials are critical components used in the manufacturing process and must meet specific technical requirements to ensure performance and compatibility within fluid handling systems. The solicitation is issued by the Fluid Handling Division of the Department of Defense, with performance designated to take place in Tracy, California, under the NAICS code 325990 which categorizes the work within other chemical product and preparation manufacturing. The opportunity was posted on July 28, 2026, with a response deadline of August 10, 2026, giving interested suppliers approximately two weeks to submit proposals. While no set-aside type is specified, the contract is structured as a subcontract, meaning the selected supplier will be providing materials to a prime contractor rather than directly to the government. The place of performance is clearly identified as Tracy, 95304-5000, and the contract opportunity is accessible through the DIBBS portal at the provided link for full solicitation details and submission instructions.

FLUID HANDLING DIVISION

POSTED

about 21 hours ago

DEADLINE

Pharmaceutical Packaging & Kitting ServicesThe contract seeks qualified vendors to provide secondary packaging, unit-of-issue kitting, and military-compliant labeling services for pharmaceutical products destined for Department of Defense distribution. All work must adhere to strict military standards to ensure compatibility, traceability, and safety within the DOD supply chain, with specific emphasis on proper documentation, barcoding, and compliance with federal and military regulations. The services are critical to preparing pharmaceuticals for efficient handling, storage, and deployment in operational environments. Performance of this subcontract is required at Fort Stewart, Georgia, with a response deadline of July 29, 2026. The Naics code 325990 designates the scope under Other Pharmaceutical and Medicine Manufacturing, indicating the specialized nature of the packaging and kitting operations. While the solicitation number and point of contact are not provided, the contract is accessible via the DIBBS portal, and interested parties must submit proposals prior to the deadline to be considered. This effort supports the Medical Supply Chain Pharm FSA’s mission to ensure timely and compliant delivery of pharmaceuticals to military personnel.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

in about 3 hours

Medical Product Packaging and Labeling ServicesThe contract requires the provision of compliant packaging, labeling, and preservation services for medical test strips in accordance with federal standards including MMS No. 1, ASTM D3951, and OSHA hazard communication requirements. The work involves ensuring all materials meet rigorous regulatory criteria for safety, durability, and labeling accuracy to support the secure handling and usage of diagnostic products within medical supply chains. The performance location is specified as Salem, Oregon with a ZIP code of 97301-0000, and the solicitation falls under NAICS code 325990 for other pharmaceutical and medicinal product manufacturing. The contract type is designated as a subcontract, and while the solicitation number is not provided, it is accessible via the DIBBS platform under the reference SPE2DH26T5431. The posting date is July 23, 2026, with a firm response deadline of July 30, 2026. The contracting authority is the Department of Defense through its Medical Supply Chain FSH organization, indicating this effort supports defense-related medical logistics and supply readiness.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Military Packaging & Marking Compliance ProviderThe contract requires adherence to stringent military packaging and marking standards for dental floss shipments, specifically complying with MIL-STD-129, ASTM D3951, and DLA technical requirements to ensure proper unit packaging, palletization, and logistical labeling. The work entails precise assembly and marking of shipments to meet Department of Defense logistics specifications, ensuring seamless handling, tracking, and distribution through military supply channels. All packaging must conform to approved procedures for durability, clarity of markings, and compatibility with automated tracking systems used across defense logistics networks. The solicitation is classified as a subcontract under NAICS code 325990, with a response deadline of July 29, 2026, and the place of performance is designated as Corpus Christi, Texas, with postal code 78419-5131. The contracting activity falls under the Medical Supply Chain FSH within the Department of Defense, indicating the shipment destination is tied to military medical logistics operations. While no set-aside designation or point of contact is provided, bidders must ensure full compliance with all technical and procedural requirements outlined in the referenced standards to qualify for award.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

in about 3 hours

Packaging, Labeling, and Marking ComplianceThe contract requires full compliance with Defense Logistics Agency standards for the packaging, labeling, and marking of pharmaceutical bottles, ensuring all items are correctly identified with the National Drug Code, Transaction Control Number, contract number, and MARKFOR address. All activities must adhere strictly to DLA specifications to maintain regulatory and logistical integrity throughout the supply chain. The work is classified under NAICS code 325990 and is structured as a subcontract under the Department of Defense, with performance anticipated to support federal medical distribution systems. The solicitation was posted in July 2026 and is accessible via the DIBBS system under the referenced contract and delivery order numbers.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling ServicesThe contract entails the provision of compliant packaging and labeling services for pharmaceutical shipments under a subcontract arrangement with the Defense Logistics Agency, a branch of the Department of Defense. The work must adhere to strict regulatory standards, requiring accurate inclusion of National Drug Code NDC identifiers, Commercial and Government Entity CAGE codes, and contract-specific identifiers to ensure traceability and compliance throughout the supply chain. The North American Industry Classification System code 325990 indicates the scope involves other miscellaneous pharmaceutical and biological product manufacturing activities related to packaging and labeling operations. The contract was posted on July 15 2026 and is tied to the procurement reference SPE2DX25D9900 with delivery order SPE2DP26F7714, indicating it supports a broader defense medical supply initiative. While specific performance locations and point of contact details are not provided the work is expected to be executed in alignment with federal pharmaceutical handling requirements to support military and veterans healthcare logistics.

Defense Logistics Agency

POSTED

DEADLINE

Packaging and Labeling Compliance (Pharmaceuticals)

Defense Logistics Agency

POSTED

DEADLINE

Connector Housing Molding

Defense Logistics Agency

POSTED

DEADLINE

High-Temperature Process Heat Application DevelopmentThis contract focuses on the development and testing of industrial processes utilizing MARVEL’s high-temperature process heat exceeding 300°C. The key applications targeted include chemical synthesis, hydrogen production, and desalination, which leverage this advanced thermal energy source to enhance efficiency and sustainability in these sectors. The contract is a subcontract opportunity issued by the Department of Energy, aimed at organizations capable of advancing these industrial technologies. The work will be performed in Idaho Falls, with a deadline for response set for August 31, 2026. The contract falls under the NAICS code 325990, which relates to industrial chemical manufacturing. Although specific organizational eligibility details and set-aside status are not specified, the opportunity represents a strategic effort by the Department of Energy to accelerate the use of high-temperature process heat in critical industrial applications, fostering innovation and potential commercialization of clean energy solutions.

ENERGY, DEPARTMENT OF

POSTED

DEADLINE

in about 1 month

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

SUNSCREEN PREPARATIONThe contract specifies the procurement of a topical sunscreen preparation meeting stringent medical and military standards, containing 4.5% titanium dioxide and 4% zinc oxide with an SPF of 50, designed to be sweat and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, biodegradable, and suitable for outdoor use. Each unit is packaged as a case of 24 three-ounce tubes with a total shelf life of 24 months, requiring a minimum of 21 months of remaining shelf life upon receipt by the first government activity, and must be stored between 15°C and 30°C in a cool, dry environment. The product is regulated by the FDA and must comply with all DLA Master List of Technical and Quality Requirements, which override any other standards including ASTM D3951 and MIL-STD-129. Packaging must adhere to Medical Marking Standard No. 1, with palletization and labeling strictly conforming to DLA’s packaging protocols, and the material is not considered hazardous under FED-STD-313, so commercial packaging per ASTM D3951 applies only where DLA requirements do not take precedence. All shipments must be sent by the fastest traceable means, excluding parcel post, with delivery FOB destination within five days of order, and zero tolerance for quantity variance. Three separate delivery line items total four pallets to be delivered to three distinct military locations: a unit in Melrose, Massachusetts; a unit at Fort Bragg, North Carolina; and the USS Gridley in FPO AP. Each shipment is tied to a unique purchase request and delivery address, with the same NSN material number assigned to all, indicating identical product specifications across all units. The contract requires exact compliance with military marking standards, packaging requirements, and shipping instructions, including adherence to DLA procedures for vessel shipments where applicable. The solicitation number is SPE2DP-26-T-4340, issued by the Department of Defense Medical Supply Chain, with a response deadline of August 3, 2026, and all deliveries must be completed no later than July 30, 2026. The unit of issue is defined as a package, and all packaging details, including quantity per unit pack and palletization, are fixed per contract terms. Manufacturer and bid details must be verified through EBS referral to ensure FDA compliance prior to award.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 21 hours ago

DEADLINE

FLUORESCEIN SODIUM OPHFluorescein Sodium Ophthalmic Strips, USP, are procured as a single unit of 100 individually sealed strips at 1 mg each, packaged in commercial unit containers designed to prevent damage or breakage, with exterior shipping containers ensuring safe and cost-effective delivery to the designated point of supply. All packaging and marking must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and must include the NSN, manufacturer, CAGE code, date of manufacture, expiration or retest date, and contract or lot number. The product has a non-extendable shelf life of 36 months as a TYPE I (CODE Q) item. Mercury and mercury-containing compounds are strictly prohibited from intentional addition or direct contact with the product, with exceptions limited to specific functional uses in batteries, lighting, instruments, sensors, controls, weapon systems, or NAVSEA-approved chemical reagents; portable fluorescent lamps or instruments containing mercury must be shockproof and include a secondary containment barrier per NAVSEA 5100-003D. Suppliers must submit Safety Data Sheets (SDS) and Hazard Communication Standard (HCS) compliant labels in accordance with 29 C.F.R. 1910.1200, replacing MSDS requirements effective June 1, 2015, and ensure employee training on all updated labeling and documentation standards. The item is regulated by the FDA, and buyers must submit referrals to confirm compliance. Delivery is FOB destination within 20 days with no variance allowed in quantity, and the product must adhere to MIL-STD-2073-1E packaging standards. The contract reference is SPE2DP-26-T-4346, with a response deadline of August 3, 2026, and the point of contact is James McCullough at DLA Troop Support.

Pharmaceutical Preparation Manufacturing

POSTED

about 21 hours ago

DEADLINE

ZINC OXIDE OINTMENTThe contract specifies the procurement of Zinc Oxide Ointment USP, a topical skin protectant containing 20% zinc oxide, packaged in 1-ounce collapsible tubes weighing 28.35 grams each, with the unit of issue being the tube. The product must comply with FDA regulations and meet stringent technical and quality standards as defined by the DLA Master List of Technical and Quality Requirements, including proper labeling per MEDICAL MARKING STANDARD NO. 1 and packaging consistent with MIL-STD-129 and RP001. The ointment has a non-extendable shelf life of 36 months and must be stored at controlled room temperature not exceeding 30°C (86°F). The item is identified by NSN 6505-00-150-1990 and manufacturer part number NDC67777-0223-11 supplied by DYNAREX CORP. Two delivery line items are specified: 10 tubes for delivery to Richmond, Virginia, and 4 tubes for delivery to Melrose, Massachusetts. Both shipments are required within five days of contract award, delivered FOB destination with zero quantity variance, inspected and accepted at the destination. Packaging must adhere to ASTM D3951 if non-hazardous, but DLA requirements supersede all others. Shipping must occur via traceable methods, excluding parcel post, and all markings must follow government specifications. The original required delivery dates are July 29 and July 30, 2026, with the contract solicitation number SPE2DP-26-T-4335 and point of contact James McCullough.

Pharmaceutical Preparation Manufacturing

POSTED

about 21 hours ago

DEADLINE

ZOLMITRIPTAN TABLETZolmitriptan tablets, 2.5 mg film-coated, are supplied in blister packs containing six tablets per package, with the unit of issue defined as a package of six units. The product must be stored at controlled room temperature and marked in accordance with the latest edition of the Medical Marking Standard No. 1, adhering to DLA packaging requirements and technical quality standards as outlined in the DLA Master List of Technical and Quality Requirements. The item is classified as a Type I (Code Q) drug with a non-extendable shelf life of 36 months, and all supplies must comply with removal of government identification if not accepted, with potential application of Covered Defense Information protocols. The contract specifies two manufacturer part numbers—NDC71626-0101-06 from Medstone Pharma LLC and NDC60846-0130-30 from Amneal Pharmaceuticals of New York, LLC—both subject to FDA regulation and requiring prior confirmation via EBS referral by the contracting official. The delivery instruction requires FOB destination within 20 days, with no variance allowed in quantity, inspection and acceptance occurring at the delivery point, and packaging must meet MIL-STD-2073-1E standards. The contract, issued under solicitation SPE2DP-26-T-4332, has a posted date of July 28, 2026, and a response deadline of August 3, 2026, with three packages totaling 18 tablets ordered at $3.00 per package. The item is linked to NSN 6505015232352 and classified under NAICS code 325412 for pharmaceutical manufacturing.

Pharmaceutical Preparation Manufacturing

POSTED

about 21 hours ago

DEADLINE

PHENYLEPHRINE HYDROThe contract specifies the procurement of Phenylephrine Hydrochloride Ophthalmic Solution USP 2.5% in 10 mL sterile, aqueous, topical bottles manufactured by Bausch & Lomb Americas Inc. with NDC 82260-0102-10, to be delivered in a quantity of six bottles under solicitation SPE2DP-26-T-4342. The product must be stored at 2°C to 25°C (36°F to 77°F) and packaged in sealed unit containers that protect against damage, with all outer shipping containers meeting commercial standards for safe transport by common carrier at the lowest cost to the designated destination in Williamsburg, VA. Packaging and marking must comply with Medical Marking Standard No. 1, replacing all references to MIL-STD-129, and palletization must follow DLA Packaging Requirements for Procurement. The item has a non-extendable shelf life of 24 months as a TYPE I (CODE M) product and must be labeled accordingly. The solution is contained in opaque white LDPE bottles with LLDPE dropper tips and red caps, and the entire shipment must be delivered FOB destination within five days of the order. Shipment must be sent by the fastest traceable means; parcel post is prohibited. Delivery is required by April 15, 2026, with inspection and acceptance occurring at the destination point. The National Stock Number is 6505017090360 and the purchase request number is 7016297029. The item is regulated by the FDA, requiring a referral to the product specialist through EBS with full bidder and manufacturer details. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with the revision in effect on the solicitation issue date controlling. Contract-specific identifiers, including CLIN, pricing, and unit of issue, are structured under the DoD authorized unit of issue system, and all documentation must reflect current DLA standards for marking, packaging, and logistics. The point of contact for inquiries is James Mariani of the Department of Defense Medical Supply Chain.

Medicinal and Botanical Manufacturing

POSTED

about 21 hours ago

DEADLINE

VERAPAMIL HYDROCHLORIDVerapamil hydrochloride injection is a 5 mg per 2 mL solution packaged in 2 mL single-dose glass fliptop vials, supplied in packs of 25, and is preservative-free for intravenous use only. The product must be protected from light and stored at controlled room temperature between 20 to 25°C (68 to 77°F), conforming to USP standards. It has a non-extendable shelf life of 24 months from the date of manufacture, and no more than four months may have elapsed between manufacture and delivery to the government. The item is identified by NSN 6505-01-738-0226 and is subject to stringent technical and quality requirements as defined in the DLA Master List, with packaging and handling governed by DLA procurement standards. Government identification must be removed from non-accepted supplies, and covered defense information provisions apply. The solicitation, issued under SPE2DP-26-T-4330 on July 28, 2026, with a response deadline of August 3, 2026, is for a federal procurement through the Department of Defense’s Medical Supply Chain PHARM FSA, with delivery required within five days of award, and the point of contact is Daniel Porter at daniel.porter@dla.mil.

Medicinal and Botanical Manufacturing

POSTED

about 21 hours ago

DEADLINE

ATROPINE SULFATE INAtropine Sulfate Injection, USP, is a sterile, nonpyrogenic, preservative-free, and non-DEHP product supplied in a 5 mL single-dose syringe with a 20-gauge by 1.5-inch protected needle featuring a male Luer lock adapter. Each milliliter contains 0.1 mg of atropine sulfate monohydrate and 9 mg of sodium chloride, resulting in a total of 0.5 mg of atropine per syringe. The medication is indicated for subcutaneous, intramuscular, or intravenous administration and is labeled RX only. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F) and has a non-extendable shelf life of 24 months. Packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and all DLA Master List of Technical and Quality Requirements take precedence over commercial packaging standards. The product is regulated by the FDA and is supplied by Pfizer Inc with NDC code 00409-4910-34. The contract, issued under solicitation number SPE2DP-26-T-4325, requires delivery of one pallet (PG) containing ten units to Fort Bragg, North Carolina, within 20 days of order placement, FOB destination. No quantity variance is permitted, and inspection and acceptance occur at the delivery point. The material is not classified as hazardous under FED-STD-313 and must be commercially packaged in accordance with ASTM D3951, unless overridden by DLA requirements. All packaging must be marked and labeled per DLA specifications, palletized as per RP001, and shipped via traceable means, excluding parcel post. The delivery is mandated for July 29, 2026, with the contract awarded to the Department of Defense, Medical Supply Chain Pharm FSA, and all technical, quality, and packaging specifications are governed by the DLA Master List in effect on the solicitation issue date. A referral must be sent via EBS to confirm bidder and manufacturer details prior to award.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 21 hours ago

DEADLINE

INSECT REPELLENT SPThe contract is for a 100% biodegradable insect repellent spray with a non-DEET formula and citrus scent, packaged in 2-ounce units, with a total quantity of 30 units required. The item is identified by NSN 6505-01-512-8504 and is part of a solicitation issued under SPE2DP-26-T-4349 with a response deadline of August 3, 2026. The product must comply with technical and quality requirements referenced in the DLA Master List of Technical and Quality Requirements, with applicable revisions determined by the solicitation or award date. Packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and copies of the standard are obtainable through DLA Troop Support or online. A current Material Safety Data Sheet (MSDS) is mandatory and must be submitted electronically to DLA.MSDS@DLA.MIL using the required cover sheet (P-75), with a physical copy included in every shipment. The repellent is classified as a hazardous material, requiring packaging that meets 49 CFR and ICAO regulations. Delivery is due within 20 days of award to Fort Campbell, Kentucky, and point of contact is Vanesa M Carbo Acevedo, with additional logistics and compliance oversight by the Department of Defense’s Medical Supply Chain Pharma FSA.

Pharmaceutical Preparation Manufacturing

POSTED

about 21 hours ago

DEADLINE

MOXIFLOXACIN HYDROCHLOMoxifloxacin Hydrochloride Tablets, 400 mg in 30-count bottles, are procured under solicitation SPE2DP-26-T-4348 with a required delivery of 10 bottles within 20 days FOB destination. Each bottle contains 30 tablets, with the unit of issue defined as a bottle, and the total quantity ordered is 10 bottles. The product must comply with strict packaging and labeling requirements as outlined in Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and must be shipped using traceable means, excluding parcel post. The item is classified as a Type I (Code Q) medical product with a non-extendable shelf life of 36 months and must be stored at controlled room temperature while avoiding high humidity. Manufacturer information is specified, with TEVA PHARMACEUTICALS USA, INC. and RISING PHARMA HOLDINGS, INC. listed as suppliers, each with designated NDC numbers. All packaging must meet commercial standards per ASTM D3951 unless the material is hazardous, in which case Federal Standard 313 applies, though DLA Master List of Technical and Quality Requirements override all other standards. The delivery destination is USS GRIDLEY DDG 101, FPO AP 96666, with shipping instructions tied to DLA Procurement Note C19 and RDD 777. The contract includes a zero variance tolerance on quantity, inspection and acceptance occur at destination, and the product is subject to FDA regulation. The solicitation requires buyers to submit referrals via EBS to confirm bidder and manufacturer details, and the contract is governed by DLA’s technical and quality requirements effective at the time of award, with all markings and packaging strictly aligned to current DLA medical marking standards.

Pharmaceutical Preparation Manufacturing

POSTED

about 21 hours ago

DEADLINE

DIETARY SUPPLEMENT, THEThe contract specifies the procurement of an unflavored therapeutic dietary supplement in powder form, with each package containing six individual packets, each yielding 8 to 10 ounces of liquid when reconstituted. The product is lactose-free and must have a shelf life of 18 months, with no more than three months elapsed between manufacture and delivery to the government. Each package must be sealed in a unit container that protects the contents from damage and packed in commercial shipping containers suitable for safe transport at the lowest cost to the delivery point. All packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must adhere to DLA’s Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. Palatalization must follow DLA Packaging Requirements for Procurement. The unit of issue is the package, with four packages required, delivered in two separate shipments to two distinct government addresses—one in Perry Point, Maryland, and another in San Antonio, Texas—by traceable freight means only, prohibiting parcel post. Delivery is required within 35 days after order date, with inspection and acceptance occurring at the destination. Pricing is firm fixed, with no variance allowed in quantity. The supplier must comply with federal clauses related to veteran employment reports, sustainable products, and wide area workflow payment. The item’s NSN is 8940-01-317-9838, and the solicitation number is SPE2DP-26-Q-0125.

Medicinal and Botanical Manufacturing

POSTED

about 21 hours ago

DEADLINE

LIDOCAINE HYDROCHLOLidocaine Hydrochloride and Epinephrine, USP, is a parenteral injectable pharmaceutical product containing a 2 percent concentration of lidocaine hydrochloride and a 1:50,000 dilution of epinephrine bitartrate, supplied in 1.7 mL single-dose cartridges. Each unit of issue consists of a package of 50 cartridges, organized in five blisters of ten per cardboard box. The product must be stored at controlled room temperature below 25°C (77°F), protected from light, and must not be frozen. It is regulated by the FDA and has a non-extendable shelf life of 18 months as a Type I (Code K) item. Packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure the product is sealed, protected from damage, and shipped in suitable commercial containers to guarantee safe delivery. Technical and quality requirements referenced in the document are governed by the DLA Master List of Technical and Quality Requirements, with revisions controlled based on solicitation or award date depending on acquisition type. This procurement is issued under Solicitation Number SPE2DP-26-T-4333 by the Department of Defense’s Medical Supply Chain Pharm FSA. One pack (PG) of 50 cartridges is required, with a delivery requirement of five days after award, delivered FOB destination to JBER, Alaska. The NSN is 6505-01-576-2767 and the purchase request number is 7017631646. The product must be supplied by an approved manufacturer with part number NDC66312-0181-16 or equivalent, and shipment must adhere to all DLA packaging standards, including commercial packaging for medical items and specific marking requirements. No quantity variance is permitted, and inspection and acceptance occur at the destination. The required delivery date is July 29, 2026, and the response deadline for the solicitation is August 3, 2026. The contracting officer must submit a referral in EBS for confirmation, including manufacturer and bidder details. Transportation and delivery logistics are governed by DLA procedural notes C19 and C20, with the point of contact for inquiries being Timothy McCauley.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 21 hours ago

DEADLINE

RINGER'S INJECTION, LACRINGER'S INJECTION, LACTATED, USP, 1000ML in packs of 12 units per case, is being procured under contract SPE2DP-26-T-4338 with a total quantity of 3 cases, each containing 12 units, for delivery to Bogalusa, LA within five days under FOB destination terms. The product must be packaged in sealed unit containers that protect against damage and shipped in commercial exterior containers suitable for safe transport by common carrier at the lowest cost, conforming to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The item, manufactured by B. BROWN MEDICAL INC with NDC 00264-7750-00, has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C) with brief exposure up to 40°C permitted; freezing and excessive heat must be avoided. All packaging and labeling must adhere to the latest version of the Medical Marking Standard No. 1, available through DLA Troop Support, and technical and quality requirements referenced by R or I numbers are governed by the DLA Master List in effect at the solicitation or award date. The contract specifies zero variance in quantity, inspection and acceptance occur at delivery point, and government identification must be removed from non-accepted supplies. The FDA regulates this drug, requiring buyer referral via EBS to the product specialist, including manufacturer and bidder details. The purchase is under the DoD unit of issue system, and procurement falls under NAICS 325412.

Pharmaceutical Preparation Manufacturing

POSTED

about 21 hours ago

DEADLINE